Discovery of N-aryl-Nâ²-pyrimidin-4-yl ureas as irreversible L858R/T790M mutant selective epidermal growth factor receptor inhibitors
Keywords: EGFR T790M; Non-small cell lung cancer; Inhibitors; Pyrimidine-4-yl urea;